Search results for “Relypsa”

Times Square Tower

document TEXT-001-HOUSE_OVERSIGHT_024003.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…in each of the other sectors. Ron is currently on the boards of Durata Therapeutics (NASDAQ: DRTX), IlluminOss Medical, Relypsa (NASDAQ: RLYP), and SpineWave. Ron was previously on the boards of Cerexa (NLV-I company acquired by Forest Laboratories), Stromedix, Inc. (NLV-I compan...

molecular immunology at The Pasteur Institute and earned an M.D. and Ph.D. from the

document IMAGES-007-HOUSE_OVERSIGHT_024023.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…in each of the other sectors. Ron is currently on the boards of Durata Therapeutics (NASDAQ: DRTX), IlluminOss Medical, Relypsa (NASDAQ: RLYP), and SpineWave. Ron was previously on the boards of Cerexa (NLV-I company acquired by Forest Laboratories), Stromedix, Inc. (NLV-I compan...

Leadership: NLV_ are leaders in biopharmaceutical investing across all stages and transaction

document IMAGES-007-HOUSE_OVERSIGHT_024045.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…mpanies. These have included Pearl Therapeutics (NLV-I, exited in sale to Astra Zeneca, 2.5x multiple plus milestones), Relypsa (NLV-I,_ private initially, now public on NASDAQ: RLYP), Convergence/Calchan Pharmaceuticals (NLV-IL, one start up that subsequently split to become 2 s...

Sprout Capital IX, L.P. (Healthcare Technology Portfolio)

document IMAGES-007-HOUSE_OVERSIGHT_024102.txt Mar 31, 2014 House Oversight Committee — Epstein Estate Records (Nov 2025)

…$ 266 $ 0.0 6$ = $ 0.0 NA Labcyte, Inc. (fka Picoliter) Diagnostics & Infrastructure 2002 $§$ 10.0 $ 2 $ 10.6 $ 10.6 NA Relypsa, Inc. Therapeutics 2007 § 203 $ 0.0 6$ 504 $ 50.4 NA Sopherion Therapeutics, Inc. Therapeutics 2004 §$ 151 $ - $ 0.0 6$ 0.0 NA Spinewave Healthcare Devi...

Results for “Relypsa”

Names that match “Relypsa”